AURKA participates in the control of NF-κB and Wnt/β-catenin pathways, associated with the resistance and progression of MM (Dutta-Simmons et al., 2009; Mazzera et al., 2013; Zhou et al., 2013; Huynh et al., 2018). Here, NFKB1 is linked to Miyoshi myopathy.